Previous Article | Next Article ![]()
Antimicrobial Agents and Chemotherapy, March 2009, p. 888-895, Vol. 53, No. 3
0066-4804/09/$08.00+0 doi:10.1128/AAC.00968-08
Copyright © 2009, American Society for Microbiology. All Rights Reserved.

D. F. Wirth,2 and
A. M. J. Oduola4
Malaria Research Laboratories, Institute for Advanced Medical Research and Training, College of Medicine, University of Ibadan, Ibadan, Nigeria,1 Department of Immunology and Infectious Diseases, Harvard School of Public Health, Boston, Massachusetts,2 Division of Experimental Therapeutics, Walter Reed Army Institute of Research, Silver Spring, Maryland,3 Special Programme for Research and Training in Tropical Diseases (WHO/TDR), Geneva, Switzerland4
Received 21 July 2008/ Returned for modification 15 August 2008/ Accepted 18 November 2008
We assessed Plasmodium falciparum mdr1 (Pfmdr1) gene polymorphisms and copy numbers as well as P. falciparum Ca2+ ATPase (PfATPase6) gene polymorphisms in 90 Nigerian children presenting with uncomplicated falciparum malaria and enrolled in a study of the efficacy of artemether-lumefantrine (AL). The nested PCR-restriction fragment length polymorphism and the quantitative real-time PCR methodologies were used to determine the alleles of the Pfmdr1 and PfATPase6 genes and the Pfmdr1 copy number variation, respectively, in patients samples collected prior to treatment and at the reoccurrence of parasites during a 42-day follow-up. The Pfmdr1 haplotype 86N-184F-1246D was significantly associated (P < 0.00001) with treatment failures and was selected for among posttreatment samples obtained from patients with newly acquired or recrudescing infections (P < 0.00001;
2 = 36.5) and in gametocytes (log rank statistic = 5; P = 0.0253) after treatment with AL. All pre- and posttreatment samples as well as gametocytes harbored a single copy of the Pfmdr1 gene and the wild-type allele (L89) at codon 89 of the PfATPase6 gene. These findings suggest that polymorphisms in the Pfmdr1 gene are under AL selection pressure. Pfmdr1 polymorphisms may result in reduction in the therapeutic efficacy of this newly adopted combination treatment for uncomplicated falciparum malaria in Saharan countries of Africa.
Published ahead of print on 15 December 2008.
Present address: Department of Public Health, Faculty of Global Health, University of South Florida, Tampa.
This article has been cited by other articles:
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»